OR WAIT null SECS
July 02, 2019
New figures published by the ABPI have revealed the continuation of significant investment by the pharmaceutical industry into R&D in the United Kingdom.
Pfizer has successfully completed its acquisition of Therachon, a privately held clinical-stage biotechnology company.
Fujifilm Irvine Scientific has announced plans to open a third manufacturing facility in Tilburg, The Netherlands.
Will EMA’s draft guideline clarify questions about the assessment of drug device combinations in relation to the EU medical devices regulation?
The Wellcome Global Monitor has demonstrated an overall positive trust in science but some concerns still remain on attitudes on vaccines.
July 01, 2019
Research from the Institute for Research in Biomedicine offers insight into the source of asymmetry between nucleic acid hybrids.
June 28, 2019
CHMP has recommended that the indication of Victoza (liraglutide) be extended to include its use in pediatric patients with Type 2 diabetes.
ABPI and BIA have issued responses to the recently published governmental guidance on European Union exit preparedness.
June 19, 2019
During its biannual meeting in Amsterdam, ICH approved four new regulatory observers and reviewed the progress made on global harmonization efforts.
CMA has issued a statement of objections provisionally finding that four pharmaceutical companies have broken competition law.